Home > Healthcare & Medical Devices > Fractional Flow Reserve Market
Fractional Flow Reserve (FFR) Market size is expected to grow at a significant rate between 2023 and 2032. Since several regions across the globe are witnessing a rise in the percentage of people being diagnosed with cardiovascular ailments, the adoption of the Fractional Flow Reserve (FFR) technique is likely to rise at a steady rate. According to the World Health Organization, 17.9 million people die from cardiovascular diseases (CVDs), which are the main cause of mortality worldwide.
FFR is a procedure that helps in measuring the blood flow and pressure in the coronary artery. The measurement gives useful insights to cardiac surgeons on whether surgery is required to remove the blockages.
According to the Centers for Disease Control and Prevention (CDC), heart-related diseases are the primary cause of death in people belonging to various racial or ethnic groups in the U.S. Around 805,000 Americans get a heart attack each year of which 605,000 are first-time heart attacks and 200,000 heart attacks occur in those who have already experienced one. Such an increasing number of people suffering from heart conditions is expected to boost the fractional flow reserve market.
Furthermore, various reliable studies have shown that patients who were screened out of angioplasty with the help of the FFR procedure did not face any adverse results. Moreover, the technique eliminated nearly one-third of the lesions, thereby bettering the quality of patient care. These benefits will positively influence the adoption of the FFR technique among healthcare experts.
Based on product, the guidewires segment is expected to hold a major share of the fractional flow reserve market over 2023-2032 as the instrument greatly helps cardiologists in determining the severity of cardiovascular disease in patients. Guidewires also help in the effortless placement of catheters that help patients better manage their condition. Since the guidewires are minute in size, they can easily pass through the arteries, thereby increasing their use among surgeons.
On the basis of application, the fractional flow reserve industry from the single-cell coronary artery disease (CAD) segment is anticipated to grow at a notable rate from 2023 to 2032 as there is a drastic change in the lifestyle and eating habits of the population. More and more people are living a sedentary lifestyle and are over-indulging in fast foods and pre-cooked foods due to their erratic schedules. Excessive consumption of junk foods and lack of physical activity led to artery blockages, which will bolster the adoption of the FFR technique for treating medical conditions.
Regionally, North America fractional flow reserve market is set to witness a substantial rise in the use of the FFR procedure as the region’s geriatric population is growing sizably every year. Moreover, according to the CDC, high blood cholesterol, smoking, and high blood pressure are the primary factors contributing to the increase in heart disorders. The rapid growth in the number of fast-food chains and the ever-expanding processed foods sector has made consumers addicted to pre-cooked foods, which will amplify the risks of coronary artery disease, thereby fostering regional industry gains through 2032.
Some of the renowned companies operating in the fractional flow reserve industry are Koninklijke Philips N.V., Opsens Medical, Abbott Laboratories, CathWorks, Pie Medical Imaging, Boston Scientific Corporation, ACIST Medical Systems, and Siemens Healthcare, among many others.